What is Zantac?
Zantac is a treatment for heartburn, acid reflux, and ulcers of the stomach and intestines. It has been voluntarily recalled because of the presence of NDMA (N-Nitrosodimethylamine) which is a probable carcinogen. We represent individuals who had negative consequences as a result of taking Zantac.
Were you taking Zantac?
N-nitrosodimethylamine (NDMA) Exposure from Zantac
NDMA is an organic chemical that has been known to have dangerous effects for more than 40 years. The FDA, EPA, and World Health Organization all classify NDMA as a carcinogen. The Agency for Toxic Substances and Disease Registry, states in their toxicological profiles that NDMA has been shown to lead to cancer in animals and it is probable that it does the same in humans. Researchers believe that NDMA is produced by the reaction between the body’s enzymes and Zantac.
Within a few years of being introduced, scientific studies began to suggest that NMDA resulted from the use of Zantac. Over the decades, many studies had similar findings. In March 2016, researchers from Stanford University published a study in Carcinogenesis in which patients’ NDMA levels increased 400x when taking Zantac. This research raised concerns about the drug and indicated a need to further study the dangers it may pose.
On September 13, 2019 the FDA, announced that low levels of N-nitrosodimethylamine (NDMA) were found in Zantac. Both the European Medicines Agency and Health Canada issued similar warnings on the same day. A voluntary recall of 14 lots of the prescription ranitidine was issued after the FDA’s warning in September.
Animal studies associated NDMA with liver cancer, colorectal cancer, and more. Scientists believe that NDMA likely affects humans similarly. That could mean that NDMA from Zantac could be associated with the following cancers.
Cancers Associated with NDMA may include, but not limited to:
- Bladder Cancer
- Stomach Cancer
- Liver Cancer
Do you believe a cancer diagnosis is linked to Zantac?
Are You Eligible for a Claim?
If you or a loved one has developed cancer after were taking Zantac, you may be eligible for compensation. Contact our attorneys for a free consultation to discuss your potential case.
Currently, there are lawsuits filed against the manufacturer of Zantac, alleging that it intentionally concealed risks and continued to distribute the medication despite the known risks.
Like millions of Americans, you may have taken this drug that was deemed to be safe and effective for a common ailment. Now you may be unfortunately stricken with a life-threatening disease that will physically, emotionally, and financially burden you and your loved ones. If you’ve lost a loved one to cancer after taking Zantac, you may be eligible for a claim as well. Let us help you and your family get justice. Call us today! You will receive:
- Free consultation over the phone
- Easy consultation, with no obligations
- Expert advice and case review from an experienced drug injury lawyer
If you or a loved one has been harmed by a dangerous drug, such as Zantac, contact us for a free consultation today. You may be entitled to financial compensation.
RECENT BLOG POSTS ABOUT DANGEROUS DRUGS
Do you need advice from a medical malpractice attorney in Columbus? Medical treatment is never without risk, but the benefits should outweigh the risks. In most cases, it does – but mistakes happen. Some don’t lead to serious harm, but there are certain errors that no...
Clark Perdue is proud of its decades long of counsel relationship with Anapol Weiss. The collaborative effort between our firms has proven effective time and again in the representation of our mutual clients. We are pleased to announce that Anapol Weiss' Senior...
The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...
In a previous post, we wrote about the FDA's investigation into the heartburn medication, Zantac, and other drugs containing ranitidine. The problem is that ranitidine has been found to contain N-Nitrosodimethylamine (“NDMA”), a suspected cancer causing agent in...
Zantac, a popular heartburn medication, has been pulled from major retailers shelves because some of its ingredients may be linked to Zantac cancer risk. The Food and Drug Administration ("FDA") continues to investigate the Zantac cancer risk, noting that "FDA is...
The Judicial Panel on Multidistrict Litigation ordered consolidation of all Taxotere hair loss cases on October 2, 2016. The panel noted that nearly 90 cases, alleging permanent hair loss resulting for the use of the chemotherapy drug, Taxotere, have been filed...